Ceftazidime-Avibactam Treatment for Klebsiella pneumoniae Bacteremia in Preterm Infants in NICU: A Clinical Experience

Ceftazidime/avibactam (CAZ/AVI) is an antibiotic combination approved for the treatment of several infections caused by multi-drug resistant (MDR) Gram-negative bacteria. Neonates admitted to the Neonatal Intensive Care Unit (NICU) are at high risk of developing bacterial infections, and the choice...

Descripción completa

Detalles Bibliográficos
Autores principales: Marino, Andrea, Pulvirenti, Sarah, Campanella, Edoardo, Stracquadanio, Stefano, Ceccarelli, Manuela, Micali, Cristina, Tina, Lucia Gabriella, Di Dio, Giovanna, Stefani, Stefania, Cacopardo, Bruno, Nunnari, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376358/
https://www.ncbi.nlm.nih.gov/pubmed/37508265
http://dx.doi.org/10.3390/antibiotics12071169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376358/
https://www.ncbi.nlm.nih.gov/pubmed/37508265
http://dx.doi.org/10.3390/antibiotics12071169

Ejemplares similares